 | • レポートコード：MRC2303C013 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、160ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：化学・材料 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査では、世界のポリビニルピロリドン市場規模が年度年には75,850トンに及び、予測期間中（2022年～2027年）、年平均7.5％で増加すると推測されています。本調査資料では、ポリビニルピロリドンの世界市場を総合的に調査をし、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、形態別（粉末、液体）分析、用途別（医薬品、食品・飲料、化粧品、接着剤、その他）分析、地域別（中国、インド、日本、アメリカ、カナダ、メキシコ、ドイツ、イギリス、イタリア、フランス、ブラジル、アルゼンチン、サウジアラビア、南アフリカ）分析、競争状況、市場機会・将来動向などを掲載しています。並びに、本書には、Alfa Aesar, Thermo Fisher Scientific、Ashland、BASF SE、Boai NKY Pharmaceuticals Ltd、Glide Chem Private Limited、Hangzhou Motto Science & Technology Co. Ltdなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のポリビニルピロリドン市場規模：形態別 - 粉末状ポリビニルピロリドンの市場規模 - 液体状ポリビニルピロリドンの市場規模 ・世界のポリビニルピロリドン市場規模：用途別 - 医薬品における市場規模 - 食品・飲料における市場規模 - 化粧品における市場規模 - 接着剤における市場規模 - その他用途における市場規模 ・世界のポリビニルピロリドン市場規模：地域別 - アジア太平洋のポリビニルピロリドン市場規模 中国のポリビニルピロリドン市場規模 インドのポリビニルピロリドン市場規模 日本のポリビニルピロリドン市場規模 … - 北米のポリビニルピロリドン市場規模 アメリカのポリビニルピロリドン市場規模 カナダのポリビニルピロリドン市場規模 メキシコのポリビニルピロリドン市場規模 … - ヨーロッパのポリビニルピロリドン市場規模 ドイツのポリビニルピロリドン市場規模 イギリスのポリビニルピロリドン市場規模 イタリアのポリビニルピロリドン市場規模 … - 南米/中東のポリビニルピロリドン市場規模 ブラジルのポリビニルピロリドン市場規模 アルゼンチンのポリビニルピロリドン市場規模 サウジアラビアのポリビニルピロリドン市場規模 … ・競争状況 ・市場機会・将来動向 |
The market for polyvinylpyrrolidone is estimated to reach around 75,850 tons by the end of this year and is expected to register a CAGR of over 7.5% during the forecast period.
COVID-19 negatively impacted the market in 2020. The COVID-19 pandemic affected all the applications of polyvinylpyrrolidone except the pharmaceutical industry. The pandemic has led to disrupted supply chains globally. Lockdowns across different countries have affected production as key manufacturing units and factories were shut. However, the industry has started recovering since then.
Key Highlights
- A major factor driving the market studied is a rising demand in the pharmaceutical industry and growing application as adhesives in the construction industry.
- The presence of substitute products in the market is supposed to hinder market growth.
- Increasing application scope in the personal care and cosmetic industry may likely act as an opportunity for the market studied.
- Asia-Pacific dominated the market and is expected to continue its dominance during the forecast period owing to the growing regional pharmaceutical industry.
Polyvinylpyrrolidone Market Trends
Rising Demand in the Pharmaceutical Industry
- Polyvinylpyrrolidone or PVP can be used in medical and health fields as a binder, excipients, coating, bounded solution of an agent, cosolvent, sterilization disinfectant, solubilizer, sustained release agent, capsule shell, a dispersion stabilizer, and others due to its excellent solubility, solubilization property, bonding capacity, complexing power, and other functions.
- The pharmaceutical industry and medicine are the earliest and probably the most well-known areas to have benefited from PVP due to its extraordinary biocompatibility and ability to create stable association compounds and complexes with various active substances.
- As per AstraZeneca, global pharmaceutical sales have been witnessing an increasing trend since 2013. The 2021 sales stood at USD 1,186 billion, almost an increase of 8% in comparison to the previous year’s total, which stood at USD 1,101 billion. Further, as per the annual report of AstraZeneca, Latin America and the Indian Subcontinent are projected for the highest growth rates in the pharmaceutical market by 2025, with 12.6% and 10.9%, respectively.
- According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America, holding the major share, followed by the European Union (excluding the United Kingdom ) with USD 287 billion at the second position, then Southeast and east Asia expected to register USD 232 billion. Although the total spending on medicines in 2020 accounted for USD 1,265.2 billion and is expected to propel the demand to generate a revenue of USD 1595 billion in 2025.
- The pharmaceutical industry in China is one of the largest in the world. The country is involved in producing generics, therapeutic medicines, active pharmaceutical ingredients, and traditional Chinese medicine. By 2023, it is projected to grow to USD 161.8 billion and occupy 30% of the global market.
- In India, the healthcare sector is expected to reach USD 372 billion by 2022, mainly driven by increasing health awareness, access to insurance, rising income, and diseases. The medical sector in India is benefiting from the growing population at a rate of 1.6% per year. An aging population of over 100 million, rising incidences of lifestyle diseases, rising incomes, and increased penetration of health insurance are fueling the industry’s growth. Therefore, the PVP market is expected to rise in the region
- As per the United Nations Department of Public Information, compared to 2017, the number of persons aged 60 or above is expected to more than double by 2050 and more than triple by 2100, rising from 962 million globally in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100.
- Owing to all the factors mentioned above, rising demand from the pharmaceutical industry is expected to drive the polyvinylpyrrolidone market over the forecast period.
Asia Pacific Region to Dominate the Market
- The Asian-Pacific region is expected to dominate the market for polyvinylpyrrolidone during the forecast period. In countries like China, India, and Japan, the demand for polyvinylpyrrolidone has been increasing in the region due to the growing pharmaceutical industry.
- In China, polyvinylpyrrolidones (PVP) are widely adopted as a safe binder and blood plasma expander in the pharma industry. China is the world’s largest producer of pharmaceutical ingredients. China’s pharmaceutical market value was ~USD 104.9 billion in 2021 and continuously increased during the forecast period. This increase may make China’s pharmaceutical market the second largest in the world, with surging revenue propelling industry value significantly closer to that of the United States.
- As of 2021, China holds 12% of the global pharmaceutical market, following the United States, responsible for 40% of the total revenue worldwide. According to Xinhua, the Chinese pharmaceuticals market generated CNY 708.75 billion (~USD 101.99 billion) in 2021, while Chinese domestic pharmaceutical companies amassed USD 502 billion in revenue.
- As part of “Made in China 2025” industrial plan, China has increased its focus on the pharmaceutical industry. Chinese governament has established an aim of reaching an average annual increase of more than 10% in R&D investment across the industry to encourage the investments in Chinese pharmaceutical R&D sectors to open new avenues of growth.
- According to the Government of India, Indian pharma exports witnessed a growth of 103% from INR 904.15 billion (~USD 11.05 billion) in FY 2013 – FY 2014 to INR 1,834.22 billion (~USD 22.42 billion) in FY 2021 – FY 2022, and it is expected to reach INR 10,300.35 billion (~USD 125.90 billion) by FY 2030. The exports achieved in FY 2021 –FY 2022 is the Pharma Sector’s best export performance ever. It is remarkable, with exports growing by almost USD 10 billion in 8 years. India has provided pharmaceutical products to more than 200 countries and may continue to do so in the future.
- Furthermore, the Indian food and beverages industry is emerging as a high-profit sector. It accounts for ~3% of India’s GDP and is the single largest employer, with more than 7.3 million workforces. In 2021, Nestle India Chairman said that the Indian packaged food market is expected to double and grow to USD 70 billion in the next 5-10 years, led by factors including economic growth, demographic dividend, and growing e-commerce.
- The pharmaceutical market in Japan has shown small growth rates in the past years. A complex regulatory and pricing process and regular price cuts have made it complicated for pharmaceutical companies to introduce new innovative products. Another reason for the stagnant market is the promotion of generic drugs adopted by the government since 2007 to reduce healthcare expenditures in Japan. Furthermore, the easy availability of pharmaceutical products online and consultation coupled with increased health concerns among the people are likely to augment the polyvinylpyrrolidone market.
- The factors mentioned above are expected to increase the demand for polyvinylpyrrolidone in the region during the forecast period.
Polyvinylpyrrolidone Market Competitor Analysis
The polyvinylpyrrolidone market is consolidated in nature. The top three players account for a major share in the market. Major companies in the market include BASF SE, Ashland, Boai NKY Pharmaceuticals Ltd, JH Nanhang Life Sciences Co. Ltd, and Huangshan Bonsun Pharmaceuticals Co. Ltd, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Rising Demand in the Pharmaceutical Industry
4.1.2 Growing Application as Adhesives in the Construction Industry
4.2 Restraints
4.2.1 Presence of Substitutes
4.3 Industry Value Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
5 MARKET SEGMENTATION (Market Size in Volume)
5.1 Form
5.1.1 Powder
5.1.2 Liquid
5.2 Application
5.2.1 Pharmaceutical
5.2.2 Food and Beverage
5.2.3 Cosmetics
5.2.4 Adhesives
5.2.5 Other Applications
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 Italy
5.3.3.4 France
5.3.3.5 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle-East
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share (%) Analysis
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Alfa Aesar, Thermo Fisher Scientific
6.4.2 Ashland
6.4.3 BASF SE
6.4.4 Boai NKY Pharmaceuticals Ltd
6.4.5 Glide Chem Private Limited
6.4.6 Hangzhou Motto Science & Technology Co. Ltd
6.4.7 Huangshan Bonsun Pharmaceuticals Co. Ltd
6.4.8 Jarchem Innovative Ingredients LLC
6.4.9 JH Nanhang Life Sciences Co. Ltd
6.4.10 Nippon Shokubai Co. Ltd
6.4.11 Shanghai Qifuqing Material Technology Co. Ltd
6.4.12 Shanghai Yuking Water Soluble Material Tech Co. Ltd
6.4.13 Zhangzhou Huafu Chemical Co. Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Increasing Application Scope in the Personal Care and Cosmetic Industry
7.2 Other Opportunities
